Simplifying Global Compliance
FDA, IMDRF Both Back Tiered Software Regulatory System
Devices & Diagnostics Letter
A federal panel is recommending that the FDA retain regulatory authority over high-risk device software, while loosening regulations around two categories considered to be lower risk.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing